Nuwellis/$NUWE
1D1W1MYTD1Y5YMAX
Capital at risk
About Nuwellis
Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
- Ticker
- $NUWE
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 38
- Headquarters
- Eden Prairie, United States
- Website
- www.nuwellis.com
Nuwellis Metrics
BasicAdvanced
$4M
-
-$145.78
0.29
-
Price and volume
Market cap
$4M
Beta
0.29
52-week high
$6.40
52-week low
$0.71
Average daily volume
3.2M
Financial strength
Current ratio
1.971
Quick ratio
1.364
Total debt to equity
-0.098
Interest coverage (TTM)
-2.12%
Profitability
EBITDA (TTM)
-12.725
Gross margin (TTM)
69.69%
Net profit margin (TTM)
-125.63%
Operating margin (TTM)
-142.87%
Revenue per employee (TTM)
$240,000
Management effectiveness
Return on assets (TTM)
-87.83%
Return on equity (TTM)
205.87%
Valuation
Price to revenue (TTM)
0.009
Price to book
-0.3
Price to tangible book (TTM)
-0.29
Price to free cash flow (TTM)
-0.007
Free cash flow yield (TTM)
-14,992.50%
Free cash flow per share (TTM)
-163.313
Growth
Revenue change (TTM)
8.36%
3-year revenue growth (CAGR)
2.76%
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.